Stress Echo 2020 - The International Stress Echo Study
NCT03049995 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-10-11
Summary
Background: Stress echocardiography (SE) has an established role in evidence-based guidelines, but recently the breadth and variety of applications has extended well beyond coronary artery disease (CAD). Purpose: To establish a prospective research study of SE applications, in and beyond CAD, also considering a variety of signs in addition to regional wall motion abnormalities. Methods: In a prospective, multicenter, international, observational study design, \> 100 certified high-volume SE labs will be networked with an organized system of clinical, laboratory and imaging data collection at the time of physical or pharmacological SE, with structured follow-up information. The study is endorsed by the Italian Society of Echocardiography and organized in 10 subprojects focusing on: contractile reserve for prediction of cardiac resynchronization or medical therapy response; stress B-lines in heart failure; hypertrophic cardiomyopathy; heart failure with preserved ejection fraction; mitral regurgitation after either transcatheter or surgical aortic valve replacement; outdoor SE in extreme physiology; right ventricular contractile reserve in repaired tetralogy of Fallot; suspected or initial pulmonary arterial hypertension; coronary flow velocity, left ventricular elastance reserve and B-lines in known or suspected CAD; identification of subclinical familial disease in phenotype-negative healthy relatives of inherited disease (such as hypertrophic cardiomyopathy). Expected Results:To collect about 10,000 patients over a 5-year period (2016-2020), with sample sizes ranging from 5,000 for known or suspected CAD to around 250 for hypertrophic cardiomyopathy or repaired Fallot. This data base will allow to investigate technical questions such as feasibility and reproducibility of various SE parameters and to assess their prognostic value in different clinical scenarios. Conclusions: The study will create the cultural, informatic and scientific infrastructure connecting high-volume, accredited SE labs, to obtain original safety, feasibility, and outcome data in evidence-poor diagnostic fields, also outside the established core application of SE in CAD based on regional wall motion abnormalities. The study will standardize procedures, validate emerging signs, and integrate the new information with established knowledge, helping to build a next-generation SE lab without inner walls.
Conditions
- Coronary Artery Disease
- Heart Failure
- Hypertrophic Cardiomyopathy
- Aortic Valve Disease
- Athletes Heart
- Tetralogy of Fallot
- Pulmonary Arterial Hypertension
Interventions
- PROCEDURE
-
Left ventricular contractile reserve SE
Stress protocols (either physical or pharmacological) will be performed according to recent guidelines recommendations (1,2,3). with special focus on Wall Motion Score Index.
- PROCEDURE
-
B-lines SE
SE will be performed with special focus on lung sonography and B-lines score (3,4).B-lines will be scored with the 28-regions antero-lateral chest assessment as previously described at baseline and immediately after stopping exercise. A simplified 8-region scan is also allowed in order to save time without loss of critical information.
- PROCEDURE
-
Left ventricular outflow tract gradient SE
SE will be performed with special focus on left ventricular outflow tract obstruction (3,4).
- PROCEDURE
-
Diastolic function SE
SE will be performed with special focus on E/e', pulmonary artery systolic pressure, B-lines and left ventricular end-diastolic volume (3,4).
- PROCEDURE
-
Mitral regurgitation SE
SE will be performed with special focus on mitral regurgitation and aortic valve gradients assessment (3,4).
- PROCEDURE
-
Pulmonary hemodynamics SE
SE will be performed with special focus on pulmonary artery systolic pressure and pulmonary artery hemodynamics.
- PROCEDURE
-
Coronary flow reserve SE
SE will be performed with special focus on regional wall motion + coronary artery flow velocity reserve.
Sponsors & Collaborators
-
Institute of Clinical Physiology, CNR, Pisa,Italy
collaborator UNKNOWN -
Salerno Hospital, Italy
collaborator UNKNOWN -
Monaldi Hospital, Napoli, Italy
collaborator UNKNOWN -
University of Pisa
collaborator OTHER -
San Luca Hospital, Lucca, Italy
collaborator UNKNOWN -
Careggi Hospital
collaborator OTHER -
Federico II University
collaborator OTHER -
San Carlo Public Hospital, Potenza, Italy
collaborator OTHER -
Royal Brompton & Harefield NHS Foundation Trust
collaborator OTHER -
Ospedale dell'Angelo, Venezia-Mestre
collaborator OTHER -
University of Parma
collaborator OTHER -
Hospital Clinics, Trieste, Italy
collaborator UNKNOWN -
Federal University of Rio Grande do Sul
collaborator OTHER -
Hospital San José, Criciuma, Brasil
collaborator UNKNOWN -
Hospital San Vicente de Paulo, Passo Fundo, Brasil
collaborator UNKNOWN -
University of Belgrade
collaborator OTHER -
University of Szeged, Hungary
collaborator UNKNOWN -
Elisabeth Hospital, Hodmezovasarhely, Hungary
collaborator UNKNOWN -
Sandro Pertini Hospital, Rome, Italy
collaborator UNKNOWN -
Hospital Clinics, Bari, Italy
collaborator UNKNOWN -
Ospedale Nottola, Siena, Italy
collaborator UNKNOWN -
University of Catania, Italy
collaborator UNKNOWN -
Medika Cardiocenter, Saint Petersburg, Russian Federation
collaborator UNKNOWN -
Acibadem City Clinic Tokuda Hospital
collaborator OTHER -
Investigaciones Medicas, Buenos Aires, Argentina
collaborator UNKNOWN -
Tomsk National Research Scientific Centre of Russian Academy of Sciences, Tomsk, Russian Federation
collaborator UNKNOWN -
Instituto Nacional de Cardiología Mexico City, Mexico
collaborator UNKNOWN -
Hamad Medical Corporation, Heart Hospital -Doha-Qatar
collaborator UNKNOWN -
Fatebenefratelli Hospital
lead OTHER
Principal Investigators
-
Quirino Ciampi, MD · Fatebenefratelli Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2020-12-31
- Completion
- 2021-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Myocardial Ischemia in Non-obstructive Coronary Artery Disease
NCT01853527 ·Status: COMPLETED
-
New Three-dimensional Methods of Analysis for the Detection of Coronary Artery Disease by Dobutamine Stress Echocardiography
NCT02240745 ·Status: COMPLETED
-
The Evaluation of Left Ventricular Systolic Function in Different Types of Ischemic Heart Disease
NCT04959357 ·Status: COMPLETED
-
Right Heart International NETwork During Exercise in Different Clinical Conditions
NCT03041337 ·Status: UNKNOWN
-
Study on the Value of Three-dimensional Speckle Tracking Technique
NCT03905200 ·Status: UNKNOWN
-
DSE vs Invasive FFR vs CT-FFR
NCT03988881 ·Status: UNKNOWN
-
TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure
NCT05250349 ·Status: RECRUITING
-
Dobutamine Stress Echocardiography in Cardiac Resynchronization Therapy (CRT) Patients Selection
NCT00828360 ·Status: UNKNOWN
-
Relation Between Aldosterone and Cardiac Remodeling After Myocardial Infarction
NCT01109225 ·Status: COMPLETED ·Phase: NA
-
Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery & Risk Area in Patients w/ NSTEMI.
NCT02014701 ·Status: UNKNOWN ·Phase: NA
-
Microembolic Detection in Acute Ischemic Stroke Patients With Atrial Fibrillation and Outcome
NCT06018090 ·Status: COMPLETED
-
Echocardiography: Value and Accuracy at REst and STress
NCT03674255 ·Status: ENROLLING_BY_INVITATION
-
Stress and Rest Myocardial Tomoscintigraphies Using Mono- or Double-isotope Protocol With a Semiconductor Camera
NCT02869126 ·Status: COMPLETED ·Phase: NA
-
Adenosine-induced Stress Dynamic Myocardial Perfusion Imaging With Dual-source CT
NCT01680081 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Analysis and Comparison of Stress Echo to Real-Time Myocardial Contrast Stress Echo
NCT00575549 ·Status: NO_LONGER_AVAILABLE
-
Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure
NCT05573997 ·Status: RECRUITING
-
Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)
NCT04335162 ·Status: COMPLETED
-
Meta-Analysis of Stress Myocardial Perfusion Imaging
NCT03180060 ·Status: COMPLETED
-
Evaluation of the Diagnostic Performance of Dynamic Myocardial Perfusion Scintigraphy in Comparison With Invasive Intracoronary FFR Measurement, in the Assessment of Significant Residual Coronary Stenosis After Acute Coronary Syndrome: Dyna-MI Pilot Study.
NCT05940285 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk
NCT05950399 ·Status: COMPLETED ·Phase: NA
-
Two- Dimensional Speckle Tracking Echocardiography After Primary Percutaneous Coronary Intervention
NCT04228510 ·Status: UNKNOWN
-
International Takotsubo Registry (InterTAK Registry)
NCT01947621 ·Status: UNKNOWN
-
MYocardial DOmmages Related to COVID-19
NCT04498065 ·Status: COMPLETED
-
Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging
NCT00156793 ·Status: COMPLETED ·Phase: PHASE3
-
Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy
NCT06372301 ·Status: RECRUITING ·Phase: NA